WWD : Balenciaga’s Cédric Charbit Is the New CEO at Saint Laurent

Balenciaga’s Cédric Charbit Is the New CEO at Saint Laurent
Gianfranco Gianangeli, previously CEO at Maison Margiela and currently chief commercial officer at YSL, is to succeed Charbit at Balenciaga.


Cédric Charbit, chief executive officer of Balenciaga since 2016, is to become the new CEO of Saint Laurent, effective Jan. 2.

Gianfranco Gianangeli, previously CEO at Maison Margiela and currently chief commercial officer at Saint Laurent, is to succeed Charbit at Balenciaga on the same date.

French group Kering, parent of both Paris-based houses, revealed the twin appointments in a statement on Monday after the close of trading on the Paris bourse.

It marks a return to Saint Laurent for Charbit, who was executive vice president of product and marketing there when he took the management helm of Balenciaga eight years ago, arriving one year after creative director Demna.

Charbit takes over the title at Saint Laurent from Francesca Bellettini, who held onto the role when last year she was promoted to Kering’s deputy CEO in charge of brand development.

All brand CEOs — Kering is parent to Bottega Veneta, Balenciaga, Alexander McQueen, Brioni, Boucheron, Pomellato, DoDo and Qeelin — report to Bellettini, who was tasked with steering these companies in their next stages of growth.

“Cédric was one of my key collaborators during my time at Saint Laurent, and I’ve always admired his leadership and unique skills,” Bellettini said, speaking exclusively to WWD. “At Balenciaga, he not only drove incredible growth but also managed to steer the brand through challenges and bring fresh momentum. I’m confident he is the perfect leader to shape the next chapter of Saint Laurent.”

Bellettini has helmed Saint Laurent since 2013, initially working with designer Hedi Slimane, who dropped the late founder’s first name, Yves, from the brand name as his first order of business. Bellettini appointed Anthony Vaccarello as creative director in 2016.

During her tenure leading the house, she grew the size of the business roughly sixfold, according to market sources.

For her part, Bellettini said she is “excited to focus entirely on my role as Kering’s deputy CEO for brand development.…With the recent changes at Gucci and all other key appointments, we’ve got the right people in place to tackle today’s challenges and set the stage for the future.”

Charbit had initially joined YSL in 2012 as director of product strategy.

Once at the helm of Saint Laurent, he will be faced with reigniting sales momentum amid a slowdown in luxury sales, especially in China, and as inflation and high interest rates weigh on discretionary spending worldwide.

Comparable sales at Saint Laurent have been decelerating in 2024: down 6 percent in the first quarter, 9 percent in the second quarter and 12 percent in the third quarter.

Kering said Charbit’s mission would be to “leverage his expertise and leadership to further develop the iconic Parisian house, building on its unique positioning, heritage and identity.”

Before YSL, Charbit was deputy general manager at Emilio Pucci. Previously, the Frenchman held management roles in retail — as general merchandise manager for womenswear at Harrods in London and Printemps in Paris.

He is a graduate of ESC Toulouse business school and is prized for his strong fashion instincts and complicity with designers.

An exuberant, straight-shooting executive, Charbit had an eventful tenure at Balenciaga, leading the hype brand through a dynamic growth phase amid lusty demand for streetwear-tinged luxury items like sneakers, caps, logo sweatshirts and heavy-duty outerwear.

He also helped Balenciaga gingerly navigate its way back into the fashion spotlight after the brand was rocked by the advertising campaign crisis at the end of 2022 over images that critics claimed promoted the exploitation of children.

Gianangeli helmed Maison Margiela from 2020 to 2023, joining the OTB-controlled house from his family-owned, namesake knitwear manufacturer in Perugia, Italy, which he had revitalized, securing production contracts for several marquee European luxury brands.

He joined Saint Laurent in September 2023, and is one of clutch of fashion CEOs from smaller brands who have recently taken on lesser C-suite roles at luxury megabrands.

Before that, he was global retail director at Givenchy and associate international director at Prada. He began his career in 2006 at Bottega Veneta in various merchandising positions and as that brand’s regional vice president in Japan.

Sources describe Gianangeli as a well-rounded executive with an entrepreneurial streak, and strong merchandising flair.

“His task [at Balenciaga] will be to continue strengthening and expanding the house’s reach and renown,” Kering said.

Bellettini has known Gianangeli since 2008, when she joined Bottega Veneta as merchandising director.

“He was working in the merchandising team, and I immediately appreciated his talents,” she told WWD. “We worked together for several years at Bottega Veneta, and we remained always in touch through all those past years.

“I have always considered him as one of the most brilliant professionals of our industry,” she continued. “When he joined Saint Laurent last year, for me he was a great addition not only for the brand but for the group, and he is the perfect successor of Cedric at Balenciaga.”

“These evolutions further reinforce our organization,” François-Henri Pinault, chairman and CEO of Kering, said in the statement. “We have the right leadership team in place to address current industry challenges and set the pace for long-term growth.”

TechCrunch : Mistral unveils new AI models and chat features.



Mistral’s Le Chat chatbot platform can now search the web — with citations in line, a la OpenAI’s ChatGPT. It’s also gained a “canvas” tool along the lines of ChatGPT Canvas, allowing users to modify, transform, or edit content, like webpage mock-ups and data visualizations, leveraging Mistral’s AI models.

“You can use [the canvas feature] to create documents, presentations, code, mockups… the list goes on,” Mistral writes in a blog post. “You’re able to modify its contents in place without regenerating responses, version your drafts, and preview your designs.”

In addition to all this, Le Chat can now process large PDF documents and images for analysis and summarization, including files containing graphs and equations. As of today, the platform incorporates Black Forest Labs‘ Flux Pro model for image generation. And Le Chat can now host shareable automated workflows for tasks like scanning expense reports and invoice processing; Mistal calls these AI “agents.”

Some of Le Chat’s new capabilities, all of which will remain free while in beta, are made possible by Mistral’s new models.

One, Pixtral Large, can process both text and images — it’s the second in Mistral’s Pixtral family of models. Weighing in at 124 billion parameters, Pixtral Large matches or bests leading models including Anthropic’s Claude 3.5 Sonnet, Google’s Gemini 1.5 Pro, and OpenAI’s GPT-4o on certain multimodal benchmarks. (Parameters roughly correspond to a model’s problem-solving skills, and models with more parameters generally perform better than those with fewer parameters.)

“Particularly, Pixtral Large is able to understand documents, charts, and natural images,” Mistral wrote in a second blog post. “The model demonstrates frontier-level image understanding.”

Mistral also today unveiled a new version of Mistral Large, its flagship line of text-only models. Called Mistral Large 24.11, the new model brings “notable improvements” in long context understanding, Mistral says, making it well-suited for use cases like document analysis and task automation.

Both Pixtral Large and Mistral Large 24.11 can be used outside of Le Chat under two licenses: a more restrictive license for research and an enterprise license for development and commercialization. Mistral Large 24.11 is already in Mistral’s API and on AI platform Hugging Face, and will soon be available through cloud platforms including Google Cloud and Microsoft Azure, Mistral says.

Paris-based Mistral, which recently raised $640 million in venture capital, continues to gradually expand its AI offerings. Over the past few months, the company has launched a free service for developers to test its models, an SDK to let customers fine-tune those models, and new models, including a generative model for code called Codestral.

Co-founded by alumni from Meta and DeepMind, Mistral’s stated mission is to create highly competitive models and services around those models — and ideally make money in the process. While the “making money” bit is proving to be challenging (as it is for most generative AI startups), Mistral reportedly began to generate revenue this summer.

“At Mistral, our approach to AI is different — we’re not chasing artificial general intelligence at all costs; our mission is to instead place frontier AI in your hands, so you get to decide what to do with advanced AI capabilities,” the company wrote in one of its blogs today. “This approach has allowed us to be quite frugal with our capital, while consistently delivering frontier capabilities at affordable price points.”

FT : LeBron James media group to merge with UK’s Fulwell 73

LeBron James media group to merge with UK’s Fulwell 73
Backers of new US-British film and TV company include Nike, RedBird Capital Partners and Liverpool FC owner Fenway

Liverpool FC owner Fenway Sports Group, Nike and US financier Todd Boehly will come together in a newly merged US-British film and TV company run by sports and entertainment veterans including NBA star LeBron James.

On Monday, LeBron’s US-based The SpringHill Company will announce a merger with Fulwell 73, a UK film, television and music production company that is co-owned by a group including actor James Corden and producer Leo Pearlman. 

As part of the merger, shareholders will invest a further $40mn to help the company to grow. 

“I don’t think there’s an independent production company anywhere in the world that can boast a group of financial partners quite as strong as this merger is going to have,” Pearlman told the Financial Times. “It’s a hell of a line-up of people who are coming into this new business.”

SpringHill is a production company founded in 2020 by James and sport marketer Maverick Carter. It has directors including Serena Williams, and the backing of Fenway, Epic Games, Nike, RedBird Capital Partners and Main Street Advisors.

The group also includes the Robot Company, a marketing agency and consultancy, and Uninterrupted, which provides a platform for athletes to produce their own content.  

Fulwell 73, the production company behind TV series including The Late Late Show with James Corden and The Kardashians, is backed by Boehly’s Eldridge Industries. 

The group is helping develop a £450mn film and TV studio complex in Sunderland, north-east England. 

Pearlman said the deal, which is expected to close this quarter, would be a “merger of equals” that would position both businesses for the next “iteration of this industry”. 

He added that the merged group would be “a global content company” with entertainment at its core that would also look at “the tangential opportunities that exist in the industry now that you have to exploit to truly be successful”.

Pearlman pointed to the growing demand for sports stars in particular to create content directly for consumers on YouTube and social channels, alongside platforms such as Netflix. “The partnership between brand and content is becoming ever more important,” he said.

Carter, who is chief executive of SpringHill, said. “Like everyone, we see the ways audience behaviour is shifting.”

The combined group has not yet agreed on a name. SpringHill is named after the housing complex where James was raised, while Fulwell 73 refers to a stand at Sunderland Football Club’s former stadium and 73 to the last time Sunderland won a major trophy.

Fulwell 73 produced the Netflix documentary series Sunderland ‘Til I Die.

“We’re trying to convince LeBron and Mav to ditch their Liverpool allegiance and become Sunderland fans with the rest of us,” Pearlman said.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • BTDR -1.4%
Other news:
  • RMBL -8.9% (Announced Record Date for Proposed $10.0 Million Rights Offering)
  • MARA -5.5% (proposed private offering of $700 million of convertible senior notes)
  • ILLR -5.1% (files for 34,741,701 shares of common stock offering by selling shareholder)
  • PPTA -4.1% (launched a public offering of 3,439,465 shares of its common stock)
  • MSGE -1.6% (CFO Michael Grau to step down)
  • HALO -1.2% (provides update on non-binding proposal to combine with Evotec (EVO))
  • NRIX -1% (Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024)
  • BHRB -1% (files $350 mixed securities shelf offering)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • TWST +18.5%, TH +6.8% (extends contract; reaffirms guidance), BRC +2.4%, NIU +0.5%
Other news:
  • RGNX +30.8% (initiates AFFINITY DUCHENNE trial of RGX-202; announced new positive efficacy and safety data from the Phase I/II portion of the study)
  • ADVM +16.6% (topline 52-week results from the LUNA Phase 2 trial, new 4-year OPTIC long-term follow-up data and key pivotal program design elements)
  • CYBN +12.5% (Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder)
  • SMCI +11.2% (Barron's article)
  • TUYA +11.2% (enters anchor investment by 65 Equity Partners)
  • RYTM +10.1% (Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide)
  • ALDX +9.3% (FDA has accepted for review the resubmitted New Drug Application for topical ocular reproxalap)
  • NTLA +7.7% (Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis)
  • SNDX +6.8% (FDA approves revumenib, a menin inhibitor, for relapsed or refractory acute leukemia)
  • TSLA +6.5% (President-elect Trump wants to ease regulations on self-driving cars)
  • FOUR +6% (to join S&P MidCap 400)
  • WOLF +5.7% (announces leadership transition; Gregg Lowe to depart as President & CEO and as a Member of the Board of Directors)
  • CAAS +4.8% (approved a share repurchase program of up to $5 million of its outstanding common shares periodically over the next 12 months)
  • LWAY +4.4% (confirms that it has received a revised, unsolicited, non-binding proposal from Danone (DANOY) North America PBC to acquire all outstanding shares of common stock of Lifeway it does not already own for $27.00 per share in cash)
  • SIGA +4% (CDC says California confirms first clade I mpox case)
  • SAVE +3.7% (enters comprehensive agreement to deleverage balance sheet; receives backstopped commitments for $350 million equity investment and $300 million in debtor-in-possession financing)
  • CABA +3.6% (Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024)
  • HY +3.2% (authorized the repurchase of up to $50 million or 1.5 million shares)
  • ARWR +3% (new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational plozasiran)
  • LRMR +2.8% (data from the Company's Phase 1 studies and the Phase 2 dose exploration study of nomlabofusp)
  • RILY +1.9% (B Riley Financial and funds managed by Oaktree Capital Management announce the launch of a partnership between B. Riley and Oaktree in the Great American Group)
  • CVS +1.7% (confirms Board appointments; Appointments follow productive engagement with Glenview Capital Management)
  • UCTT +1.6% (insider bought 15,000 shares at $34.50 - $35.00 worth almost $523K)
  • CATX +1.3% (to discuss data on [212Pb]VMT-a-NET presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024)
  • BMRN +1% (Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024)
  • GL +1% (approved an authorization to repurchase up to $1.8 billion of common stock)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Air Products (APD) upgraded to Buy from Neutral at UBS; tgt $375
    • Amylyx Pharmaceuticals (AMLX) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $11
    • Autolus Therapeutics (AUTL) upgraded to Buy from Neutral at Goldman; tgt raised to $7.60
    • Bright Horizons (BFAM) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt lowered to $125
    • CVS Health (CVS) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $66
    • Hewlett Packard Enterprise (HPE) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $29
    • MBIA (MBI) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $9
    • Moderna (MRNA) upgraded to Buy from Hold at HSBC Securities; tgt $58
    • Monolithic Power (MPWR) upgraded to Buy from Hold at Loop Capital; tgt $660
    • Robinhood Markets (HOOD) upgraded to Buy from Hold at Needham; tgt $40
    • Roku (ROKU) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $90
    • United Fire Group (UFCS) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $26
  • Downgrades:
    • Avis Budget (CAR) downgraded to Neutral from Buy at Northcoast
    • Biogen (BIIB) downgraded to Hold from Buy at Needham
    • Crane (CR) downgraded to Hold from Buy at Stifel; tgt $176
    • Curtiss-Wright (CW) downgraded to Hold from Buy at Stifel; tgt $370
    • EOG Resources (EOG) downgraded to Neutral from Overweight at Piper Sandler; tgt raised to $149
    • ESAB Corp. (ESAB) downgraded to Hold from Buy at Stifel; tgt lowered to $130
    • Eyenovia (EYEN) downgraded to Neutral from Buy at H.C. Wainwright; tgt lowered to $2
    • FB Financial (FBK) downgraded to Market Perform from Outperform at Hovde Group; tgt $60
    • Ingersoll-Rand (IR) downgraded to Hold from Buy at Stifel; tgt lowered to $107
    • Liberty Global (LBTYA) downgraded to Neutral from Buy at UBS; tgt lowered to $13
    • Matson (MATX) downgraded to Peer Perform from Outperform at Wolfe Research
    • National Bank (NBHC) downgraded to Market Perform from Outperform at Hovde Group; tgt $55
    • Parker-Hannifin (PH) downgraded to Hold from Buy at Stifel; tgt $691
    • Pinnacle Finl (PNFP) downgraded to Market Perform from Outperform at Hovde Group; tgt $135
    • Pinnacle West (PNW) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $91
    • Redfin (RDFN) downgraded to Sell from Neutral at Goldman; tgt raised to $6.50
  • Others:
    • Akero Therapeutics (AKRO) initiated with a Buy at Citigroup; tgt $65
    • Astera Labs (ALAB) initiated with a Buy at Citigroup; tgt $120
    • Capricor Therapeutics (CAPR) initiated with a Buy at JonesResearch
    • enGene Holdings (ENGN) initiated with a Mkt Outperform at JMP Securities; tgt $18
    • Erasca (ERAS) initiated with a Buy at Jefferies; tgt $6
    • GATX (GATX) initiated with a Buy at Goldman; tgt $185
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Loop Capital; tgt $30
    • Ingram Micro Holding Corp. (INGM) initiated with an Outperform at Raymond James; tgt $28
    • Ingram Micro Holding Corp. (INGM) initiated with an Equal-Weight at Morgan Stanley; tgt $24
    • Ingram Micro Holding Corp. (INGM) initiated with a Neutral at Exane BNP Paribas; tgt $25
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Stifel; tgt $28
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Deutsche Bank; tgt $26
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at BofA Securities; tgt $30
    • Ingram Micro Holding Corp. (INGM) initiated with an Outperform at RBC Capital Mkts; tgt $26
    • Ingram Micro Holding Corp. (INGM) initiated with an In-line at Evercore ISI; tgt $27
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Jefferies; tgt $28
    • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Redburn Atlantic; tgt $30
    • Korro Bio (KRRO) initiated with a Buy at JonesResearch
    • Penguin Solutions (PENG) initiated with a Mkt Outperform at JMP Securities; tgt $23
    • RXO, Inc. (RXO) resumed with a Neutral at Goldman; tgt $29
    • TechnipFMC (FTI) initiated with an Outperform at RBC Capital Mkts; tgt $37
    • Trinity Industries (TRN) initiated with a Neutral at Goldman; tgt $39
    • VYNE Therapeutics (VYNE) initiated with a Buy at BTIG Research; tgt $8

>>> Europe : Brokers Upgrades & Downgrades - 18th of November 2024 V3(++)

>>> Up
* Ahold Delhaize Raised to Buy at HSBC; PT 37 euros
* Anglo American Raised to Buy at SBG Securities; PT 2,700 pence (++)
* Argenx ADRs PT Raised to $675 from $580 at Morgan Stanley (+)
* ASR Nederland Raised to Buy at UBS (+)
* Bavarian Nordic Raised to Buy at Carnegie; PT 245 kroner (++)
* Austevoll Seafood Raised to Buy at Fearnley; PT 115 kroner
* Bioretec Raised to Accumulate at Inderes; PT 2.40 euros
* Ence Raised to Buy at Jefferies, Pulp Prices Nearing Floor Level
* Generali PT Raised to 31.10 euros from 28.70 euros at Citi
* Givaudan Raised to Buy at Research Partners (+)
* Hays Raised to Buy at HSBC; PT 100 pence
* Judges Scientific PT Cut to 11,000 pence at Panmure Liberum (+)
* Moderna Raised to Buy at HSBC; PT $58 (++)
* Nilfisk Raised to Buy at SEB Equities; PT 130 kroner
* OTP Bank Raised to Overweight at Morgan Stanley
* Puuilo Raised to Accumulate at OP Corporate Bank; PT 10.50 euros (++)
* Schindler PT Raised to 295 Swiss francs at Bernstein
* Scor Target Raised to EUR28 From EUR18 by Keefe, Bruyette & Woods (+)
* Siemens Energy Raised to Reduce at AlphaValue/Baader
* SThree Raised to Buy at HSBC; PT 420 pence
* Tesla PT Raised to $270 from $235 at Barclays (+)
* Vallourec Raised to Buy at CIC; PT 21 euros (+)
* Walmart PT Raised to $93 from $83 at Piper Sandler (++)

>>> Down
* Alstom Cut to Neutral at CIC; PT 24 euros (+)
* Bechtle Cut to Neutral at Oddo BHF; PT 37 euros
* BW Offshore Cut to Hold at Pareto Securities; PT 27 kroner
* Equinor Cut to Sell at DNB Markets; PT 200 kroner (+)
* GSK Target Cut to GBP13.50 From GBP17.00 by Deutsche Bank (+)
* Knaus Tabbert Cut to Hold at Kepler Cheuvreux (+)
* NIBE Industrier Cut to Reduce at Inderes; PT 52 kronor (+)
* Pekao Cut to Equal-Weight at Morgan Stanley; PT 177 zloty
* Piraeus Bank Cut to Equal-Weight at Morgan Stanley
* Porsche SE Cut to Reduce at HSBC; PT 26 euros

>>> Initiation
* Gabriel Cut to Reduce at Inderes; PT 225 kroner (++)
* Hermes Rated New Buy at Intesa Sanpaolo; PT 2,390 euros (+)
* Home Depot Rated New Buy at Sealand Securities
* Kitwave Group Rated New Buy at Cavendish; PT 450 pence (+)
* Netflix Rated New Buy at Mirae Asset Securities; PT $1,184
* Sea1 offshore Inc Rated New Buy at Arctic Securities
* Sunrise Communications Rated New Neutral at New Street Research
* Sunrise Communications Rated New Underweight at Barclays
* TechnipFMC Reinstated Outperform at RBC; PT $37
* Viridien Rated New Buy at Arctic Securities; PT 66 euros

>>> Call
* Bavarian Nordic Gains After Carnegie Upgrades, US Mpox Case (++)
* Morgan Stanley’s Wilson Sees S&P 500 Rallying 11% By End of 2025 (++)
* Ence Rises as Jefferies Upgrades, Pulp Prices Nearing Floor (++)
* Expected Earnings Move in Nvidia Inline with History: Barclays (+)
* Fugro Rises on New Buyback Following ‘Unwarranted’ Selloff: KBC (++)
* Buzzi Downgraded to Hold at Berenberg Following Strong Run
* Morgan Stanley Turns More Selective Within CEE and Greek Banks
* Morgan Stanley picks China stocks to ride out a worst-case scenario in U.S. tensions
* Schindler PT to Street-High at Bernstein on Modernization Upside

>>> Europe : Brokers Upgrades & Downgrades - 18th of November 2024 V2(+)

>>> Up
* Ahold Delhaize Raised to Buy at HSBC; PT 37 euros
* Argenx ADRs PT Raised to $675 from $580 at Morgan Stanley (+)
* ASR Nederland Raised to Buy at UBS (+)
* Austevoll Seafood Raised to Buy at Fearnley; PT 115 kroner
* Bioretec Raised to Accumulate at Inderes; PT 2.40 euros
* Ence Raised to Buy at Jefferies, Pulp Prices Nearing Floor Level
* Generali PT Raised to 31.10 euros from 28.70 euros at Citi
* Givaudan Raised to Buy at Research Partners (+)
* Hays Raised to Buy at HSBC; PT 100 pence
* Judges Scientific PT Cut to 11,000 pence at Panmure Liberum (+)
* Nilfisk Raised to Buy at SEB Equities; PT 130 kroner
* OTP Bank Raised to Overweight at Morgan Stanley
* Schindler PT Raised to 295 Swiss francs at Bernstein
* Scor Target Raised to EUR28 From EUR18 by Keefe, Bruyette & Woods (+)
* Siemens Energy Raised to Reduce at AlphaValue/Baader
* SThree Raised to Buy at HSBC; PT 420 pence
* Tesla PT Raised to $270 from $235 at Barclays (+)
* Vallourec Raised to Buy at CIC; PT 21 euros (+)

>>> Down
* Alstom Cut to Neutral at CIC; PT 24 euros (+)
* Bechtle Cut to Neutral at Oddo BHF; PT 37 euros
* BW Offshore Cut to Hold at Pareto Securities; PT 27 kroner
* Equinor Cut to Sell at DNB Markets; PT 200 kroner (+)
* GSK Target Cut to GBP13.50 From GBP17.00 by Deutsche Bank (+)
* Knaus Tabbert Cut to Hold at Kepler Cheuvreux (+)
* NIBE Industrier Cut to Reduce at Inderes; PT 52 kronor (+)
* Pekao Cut to Equal-Weight at Morgan Stanley; PT 177 zloty
* Piraeus Bank Cut to Equal-Weight at Morgan Stanley
* Porsche SE Cut to Reduce at HSBC; PT 26 euros

>>> Initiation
* Hermes Rated New Buy at Intesa Sanpaolo; PT 2,390 euros (+)
* Home Depot Rated New Buy at Sealand Securities
* Kitwave Group Rated New Buy at Cavendish; PT 450 pence (+)
* Netflix Rated New Buy at Mirae Asset Securities; PT $1,184
* Sea1 offshore Inc Rated New Buy at Arctic Securities
* Sunrise Communications Rated New Neutral at New Street Research
* Sunrise Communications Rated New Underweight at Barclays
* TechnipFMC Reinstated Outperform at RBC; PT $37
* Viridien Rated New Buy at Arctic Securities; PT 66 euros

>>> Call
* Expected Earnings Move in Nvidia Inline with History: Barclays (+)
* Buzzi Downgraded to Hold at Berenberg Following Strong Run
* Morgan Stanley Turns More Selective Within CEE and Greek Banks
* Morgan Stanley picks China stocks to ride out a worst-case scenario in U.S. tensions
* Schindler PT to Street-High at Bernstein on Modernization Upside

>>> Stoxx 600 Pre-Market Indications

  • Rolls-Royce (RRU TH) +3.1%
  • BT (BTQ TH) +2.8%
  • Bavarian Nordic (BV3 TH) +2.8%
  • GSK (GS71 TH) +1.9%
  • Serco (SEO TH) +1.7%
  • Rheinmetall (RHM TH) +1.5%
  • Delivery Hero (DHER TH) +1.5%
  • Porsche SE (PAH3 TH) -1.2%
    • Porsche SE Cut to Reduce at HSBC; PT 26 euros
  • Nexans (NXS TH) -1.2%
  • IAG (INR TH) -1.3%
  • NIBE Industrier (NJB TH) -1.3%
  • Telefonica (TNE5 TH) -1.4%
  • OMV (OMV TH) -1.6%
  • Bechtle (BC8 TH) -2.1%
    • Bechtle Cut to Neutral at Oddo BHF; PT 37 euros